| 发明名称 |
METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER |
| 摘要 |
The present invention concerns the use of interleukin-8 (IL-8) as a biomarker for predicting the outcome of the treatment with aflibercept, or ziv-aflibercept of a patient suspected to suffer from a cancer. |
| 申请公布号 |
US2017121387(A1) |
申请公布日期 |
2017.05.04 |
| 申请号 |
US201715408827 |
申请日期 |
2017.01.18 |
| 申请人 |
SANOFI |
发明人 |
CHIRON-BLONDEL Marielle;LAMBRECHTS Diether;MAGHERINI Emmanuelle;THUILLIER Vincent |
| 分类号 |
C07K14/71;A61K31/282;A61K9/00;A61K31/519;A61K31/4745;G01N33/574;A61K31/513 |
主分类号 |
C07K14/71 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating a patient with a cancer with aflibercept, or ziv-aflibercept, comprising administering patient therapeutically effective amount of aflibercept, or ziv-aflibercept, wherein a biological sample obtained from the patient has an interleukin-8 (IL-8) level that is lower than a reference level of IL-8. |
| 地址 |
Paris FR |
